1. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure;Maslowski, A.H.; Ikram, H.; Nicholls, M.G.; Espiner, E.A.;Lancet,1981
2. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure;Dzau, V.J.; Colucci, W.S.; Williams, G.H.; Curfman, G.; Meggs, L.; Hollenberg, N.K.;N Engl J Med,1980
3. A new class of angiotensin-converting enzyme inhibitors;Patchett, A.A.; Harris, E.; Tristram, E.W.;Nature,1980
4. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421";Gavras, H.; Biollaz, J.; Waeber, B.; Brunner, H.R.; Gavras, I.; Davies, R.O.;Lancet,1981
5. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease;Patterson, J.A.; Naughton, J.; Pietras, R.J.; Gunnar, R.M.;Am J Cardiol,1972